Eintrag weiter verarbeiten
Metabolic profile of antipsychotic-naive individuals with non-affective psychosis
Gespeichert in:
Zeitschriftentitel: | British Journal of Psychiatry |
---|---|
Personen und Körperschaften: | , , , , , , , , |
In: | British Journal of Psychiatry, 194, 2009, 5, S. 434-438 |
Format: | E-Article |
Sprache: | Englisch |
veröffentlicht: |
Royal College of Psychiatrists
|
Schlagwörter: |
author_facet |
Fernandez-Egea, Emilio Bernardo, Miguel Donner, Thomas Conget, Ignacio Parellada, Eduard Justicia, Azucena Esmatjes, Enric Garcia-Rizo, Clemente Kirkpatrick, Brian Fernandez-Egea, Emilio Bernardo, Miguel Donner, Thomas Conget, Ignacio Parellada, Eduard Justicia, Azucena Esmatjes, Enric Garcia-Rizo, Clemente Kirkpatrick, Brian |
---|---|
author |
Fernandez-Egea, Emilio Bernardo, Miguel Donner, Thomas Conget, Ignacio Parellada, Eduard Justicia, Azucena Esmatjes, Enric Garcia-Rizo, Clemente Kirkpatrick, Brian |
spellingShingle |
Fernandez-Egea, Emilio Bernardo, Miguel Donner, Thomas Conget, Ignacio Parellada, Eduard Justicia, Azucena Esmatjes, Enric Garcia-Rizo, Clemente Kirkpatrick, Brian British Journal of Psychiatry Metabolic profile of antipsychotic-naive individuals with non-affective psychosis Psychiatry and Mental health |
author_sort |
fernandez-egea, emilio |
spelling |
Fernandez-Egea, Emilio Bernardo, Miguel Donner, Thomas Conget, Ignacio Parellada, Eduard Justicia, Azucena Esmatjes, Enric Garcia-Rizo, Clemente Kirkpatrick, Brian 0007-1250 1472-1465 Royal College of Psychiatrists Psychiatry and Mental health http://dx.doi.org/10.1192/bjp.bp.108.052605 <jats:sec><jats:title>Background</jats:title><jats:p>Some studies suggest individuals with schizophrenia have an increased risk of diabetes prior to antipsychotic use. Small sample sizes and the potential for confounding by hypercortisolaemia have decreased confidence in those results.</jats:p></jats:sec><jats:sec><jats:title>Aims</jats:title><jats:p>To examine diabetes-related factors in newly diagnosed, antipsychotic-naive people with non-affective psychosis.</jats:p></jats:sec><jats:sec><jats:title>Method</jats:title><jats:p>Participants with psychosis (the psychosis group;<jats:italic>n</jats:italic>= 50) and matched controls (the control group;<jats:italic>n</jats:italic>= 50) were given a 2 h oral glucose tolerance test. Fasting concentrations were also determined for adiponectin, interleukin-6 and C-reactive protein.</jats:p></jats:sec><jats:sec><jats:title>Results</jats:title><jats:p>Compared with the control group, the psychosis group had significant increases in 2 h glucose and interleukin-6 concentrations, and in the prevalence of abnormal glucose tolerance (16% of psychosis group<jats:italic>v.</jats:italic>0% of control group). Adiponectin and C-reactive protein concentrations did not differ significantly between the two groups. These findings could not be attributed to differences in cortisol concentrations, smoking, gender, neighbourhood of residence, body mass index, aerobic conditioning, ethnicity, socioeconomic status or age.</jats:p></jats:sec><jats:sec><jats:title>Conclusions</jats:title><jats:p>Individuals with non-affective psychosis appear to have an increased prevalence of abnormal glucose tolerance prior to antipsychotic treatment, as well as abnormalities in a related inflammatory molecule. These underlying problems may contribute to the metabolic side-effects of antipsychotic medications.</jats:p></jats:sec> Metabolic profile of antipsychotic-naive individuals with non-affective psychosis British Journal of Psychiatry |
doi_str_mv |
10.1192/bjp.bp.108.052605 |
facet_avail |
Online Free |
finc_class_facet |
Medizin Psychologie |
format |
ElectronicArticle |
fullrecord |
blob:ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuMTE5Mi9ianAuYnAuMTA4LjA1MjYwNQ |
id |
ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuMTE5Mi9ianAuYnAuMTA4LjA1MjYwNQ |
institution |
DE-Ch1 DE-L229 DE-D275 DE-Bn3 DE-Brt1 DE-Zwi2 DE-D161 DE-Gla1 DE-Zi4 DE-15 DE-Pl11 DE-Rs1 DE-105 DE-14 |
imprint |
Royal College of Psychiatrists, 2009 |
imprint_str_mv |
Royal College of Psychiatrists, 2009 |
issn |
0007-1250 1472-1465 |
issn_str_mv |
0007-1250 1472-1465 |
language |
English |
mega_collection |
Royal College of Psychiatrists (CrossRef) |
match_str |
fernandezegea2009metabolicprofileofantipsychoticnaiveindividualswithnonaffectivepsychosis |
publishDateSort |
2009 |
publisher |
Royal College of Psychiatrists |
recordtype |
ai |
record_format |
ai |
series |
British Journal of Psychiatry |
source_id |
49 |
title |
Metabolic profile of antipsychotic-naive individuals with non-affective psychosis |
title_unstemmed |
Metabolic profile of antipsychotic-naive individuals with non-affective psychosis |
title_full |
Metabolic profile of antipsychotic-naive individuals with non-affective psychosis |
title_fullStr |
Metabolic profile of antipsychotic-naive individuals with non-affective psychosis |
title_full_unstemmed |
Metabolic profile of antipsychotic-naive individuals with non-affective psychosis |
title_short |
Metabolic profile of antipsychotic-naive individuals with non-affective psychosis |
title_sort |
metabolic profile of antipsychotic-naive individuals with non-affective psychosis |
topic |
Psychiatry and Mental health |
url |
http://dx.doi.org/10.1192/bjp.bp.108.052605 |
publishDate |
2009 |
physical |
434-438 |
description |
<jats:sec><jats:title>Background</jats:title><jats:p>Some studies suggest individuals with schizophrenia have an increased risk of diabetes prior to antipsychotic use. Small sample sizes and the potential for confounding by hypercortisolaemia have decreased confidence in those results.</jats:p></jats:sec><jats:sec><jats:title>Aims</jats:title><jats:p>To examine diabetes-related factors in newly diagnosed, antipsychotic-naive people with non-affective psychosis.</jats:p></jats:sec><jats:sec><jats:title>Method</jats:title><jats:p>Participants with psychosis (the psychosis group;<jats:italic>n</jats:italic>= 50) and matched controls (the control group;<jats:italic>n</jats:italic>= 50) were given a 2 h oral glucose tolerance test. Fasting concentrations were also determined for adiponectin, interleukin-6 and C-reactive protein.</jats:p></jats:sec><jats:sec><jats:title>Results</jats:title><jats:p>Compared with the control group, the psychosis group had significant increases in 2 h glucose and interleukin-6 concentrations, and in the prevalence of abnormal glucose tolerance (16% of psychosis group<jats:italic>v.</jats:italic>0% of control group). Adiponectin and C-reactive protein concentrations did not differ significantly between the two groups. These findings could not be attributed to differences in cortisol concentrations, smoking, gender, neighbourhood of residence, body mass index, aerobic conditioning, ethnicity, socioeconomic status or age.</jats:p></jats:sec><jats:sec><jats:title>Conclusions</jats:title><jats:p>Individuals with non-affective psychosis appear to have an increased prevalence of abnormal glucose tolerance prior to antipsychotic treatment, as well as abnormalities in a related inflammatory molecule. These underlying problems may contribute to the metabolic side-effects of antipsychotic medications.</jats:p></jats:sec> |
container_issue |
5 |
container_start_page |
434 |
container_title |
British Journal of Psychiatry |
container_volume |
194 |
format_de105 |
Article, E-Article |
format_de14 |
Article, E-Article |
format_de15 |
Article, E-Article |
format_de520 |
Article, E-Article |
format_de540 |
Article, E-Article |
format_dech1 |
Article, E-Article |
format_ded117 |
Article, E-Article |
format_degla1 |
E-Article |
format_del152 |
Buch |
format_del189 |
Article, E-Article |
format_dezi4 |
Article |
format_dezwi2 |
Article, E-Article |
format_finc |
Article, E-Article |
format_nrw |
Article, E-Article |
_version_ |
1792348616051916807 |
geogr_code |
not assigned |
last_indexed |
2024-03-01T18:13:58.419Z |
geogr_code_person |
not assigned |
openURL |
url_ver=Z39.88-2004&ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fvufind.svn.sourceforge.net%3Agenerator&rft.title=Metabolic+profile+of+antipsychotic-naive+individuals+with+non-affective+psychosis&rft.date=2009-05-01&genre=article&issn=1472-1465&volume=194&issue=5&spage=434&epage=438&pages=434-438&jtitle=British+Journal+of+Psychiatry&atitle=Metabolic+profile+of+antipsychotic-naive+individuals+with+non-affective+psychosis&aulast=Kirkpatrick&aufirst=Brian&rft_id=info%3Adoi%2F10.1192%2Fbjp.bp.108.052605&rft.language%5B0%5D=eng |
SOLR | |
_version_ | 1792348616051916807 |
author | Fernandez-Egea, Emilio, Bernardo, Miguel, Donner, Thomas, Conget, Ignacio, Parellada, Eduard, Justicia, Azucena, Esmatjes, Enric, Garcia-Rizo, Clemente, Kirkpatrick, Brian |
author_facet | Fernandez-Egea, Emilio, Bernardo, Miguel, Donner, Thomas, Conget, Ignacio, Parellada, Eduard, Justicia, Azucena, Esmatjes, Enric, Garcia-Rizo, Clemente, Kirkpatrick, Brian, Fernandez-Egea, Emilio, Bernardo, Miguel, Donner, Thomas, Conget, Ignacio, Parellada, Eduard, Justicia, Azucena, Esmatjes, Enric, Garcia-Rizo, Clemente, Kirkpatrick, Brian |
author_sort | fernandez-egea, emilio |
container_issue | 5 |
container_start_page | 434 |
container_title | British Journal of Psychiatry |
container_volume | 194 |
description | <jats:sec><jats:title>Background</jats:title><jats:p>Some studies suggest individuals with schizophrenia have an increased risk of diabetes prior to antipsychotic use. Small sample sizes and the potential for confounding by hypercortisolaemia have decreased confidence in those results.</jats:p></jats:sec><jats:sec><jats:title>Aims</jats:title><jats:p>To examine diabetes-related factors in newly diagnosed, antipsychotic-naive people with non-affective psychosis.</jats:p></jats:sec><jats:sec><jats:title>Method</jats:title><jats:p>Participants with psychosis (the psychosis group;<jats:italic>n</jats:italic>= 50) and matched controls (the control group;<jats:italic>n</jats:italic>= 50) were given a 2 h oral glucose tolerance test. Fasting concentrations were also determined for adiponectin, interleukin-6 and C-reactive protein.</jats:p></jats:sec><jats:sec><jats:title>Results</jats:title><jats:p>Compared with the control group, the psychosis group had significant increases in 2 h glucose and interleukin-6 concentrations, and in the prevalence of abnormal glucose tolerance (16% of psychosis group<jats:italic>v.</jats:italic>0% of control group). Adiponectin and C-reactive protein concentrations did not differ significantly between the two groups. These findings could not be attributed to differences in cortisol concentrations, smoking, gender, neighbourhood of residence, body mass index, aerobic conditioning, ethnicity, socioeconomic status or age.</jats:p></jats:sec><jats:sec><jats:title>Conclusions</jats:title><jats:p>Individuals with non-affective psychosis appear to have an increased prevalence of abnormal glucose tolerance prior to antipsychotic treatment, as well as abnormalities in a related inflammatory molecule. These underlying problems may contribute to the metabolic side-effects of antipsychotic medications.</jats:p></jats:sec> |
doi_str_mv | 10.1192/bjp.bp.108.052605 |
facet_avail | Online, Free |
finc_class_facet | Medizin, Psychologie |
format | ElectronicArticle |
format_de105 | Article, E-Article |
format_de14 | Article, E-Article |
format_de15 | Article, E-Article |
format_de520 | Article, E-Article |
format_de540 | Article, E-Article |
format_dech1 | Article, E-Article |
format_ded117 | Article, E-Article |
format_degla1 | E-Article |
format_del152 | Buch |
format_del189 | Article, E-Article |
format_dezi4 | Article |
format_dezwi2 | Article, E-Article |
format_finc | Article, E-Article |
format_nrw | Article, E-Article |
geogr_code | not assigned |
geogr_code_person | not assigned |
id | ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuMTE5Mi9ianAuYnAuMTA4LjA1MjYwNQ |
imprint | Royal College of Psychiatrists, 2009 |
imprint_str_mv | Royal College of Psychiatrists, 2009 |
institution | DE-Ch1, DE-L229, DE-D275, DE-Bn3, DE-Brt1, DE-Zwi2, DE-D161, DE-Gla1, DE-Zi4, DE-15, DE-Pl11, DE-Rs1, DE-105, DE-14 |
issn | 0007-1250, 1472-1465 |
issn_str_mv | 0007-1250, 1472-1465 |
language | English |
last_indexed | 2024-03-01T18:13:58.419Z |
match_str | fernandezegea2009metabolicprofileofantipsychoticnaiveindividualswithnonaffectivepsychosis |
mega_collection | Royal College of Psychiatrists (CrossRef) |
physical | 434-438 |
publishDate | 2009 |
publishDateSort | 2009 |
publisher | Royal College of Psychiatrists |
record_format | ai |
recordtype | ai |
series | British Journal of Psychiatry |
source_id | 49 |
spelling | Fernandez-Egea, Emilio Bernardo, Miguel Donner, Thomas Conget, Ignacio Parellada, Eduard Justicia, Azucena Esmatjes, Enric Garcia-Rizo, Clemente Kirkpatrick, Brian 0007-1250 1472-1465 Royal College of Psychiatrists Psychiatry and Mental health http://dx.doi.org/10.1192/bjp.bp.108.052605 <jats:sec><jats:title>Background</jats:title><jats:p>Some studies suggest individuals with schizophrenia have an increased risk of diabetes prior to antipsychotic use. Small sample sizes and the potential for confounding by hypercortisolaemia have decreased confidence in those results.</jats:p></jats:sec><jats:sec><jats:title>Aims</jats:title><jats:p>To examine diabetes-related factors in newly diagnosed, antipsychotic-naive people with non-affective psychosis.</jats:p></jats:sec><jats:sec><jats:title>Method</jats:title><jats:p>Participants with psychosis (the psychosis group;<jats:italic>n</jats:italic>= 50) and matched controls (the control group;<jats:italic>n</jats:italic>= 50) were given a 2 h oral glucose tolerance test. Fasting concentrations were also determined for adiponectin, interleukin-6 and C-reactive protein.</jats:p></jats:sec><jats:sec><jats:title>Results</jats:title><jats:p>Compared with the control group, the psychosis group had significant increases in 2 h glucose and interleukin-6 concentrations, and in the prevalence of abnormal glucose tolerance (16% of psychosis group<jats:italic>v.</jats:italic>0% of control group). Adiponectin and C-reactive protein concentrations did not differ significantly between the two groups. These findings could not be attributed to differences in cortisol concentrations, smoking, gender, neighbourhood of residence, body mass index, aerobic conditioning, ethnicity, socioeconomic status or age.</jats:p></jats:sec><jats:sec><jats:title>Conclusions</jats:title><jats:p>Individuals with non-affective psychosis appear to have an increased prevalence of abnormal glucose tolerance prior to antipsychotic treatment, as well as abnormalities in a related inflammatory molecule. These underlying problems may contribute to the metabolic side-effects of antipsychotic medications.</jats:p></jats:sec> Metabolic profile of antipsychotic-naive individuals with non-affective psychosis British Journal of Psychiatry |
spellingShingle | Fernandez-Egea, Emilio, Bernardo, Miguel, Donner, Thomas, Conget, Ignacio, Parellada, Eduard, Justicia, Azucena, Esmatjes, Enric, Garcia-Rizo, Clemente, Kirkpatrick, Brian, British Journal of Psychiatry, Metabolic profile of antipsychotic-naive individuals with non-affective psychosis, Psychiatry and Mental health |
title | Metabolic profile of antipsychotic-naive individuals with non-affective psychosis |
title_full | Metabolic profile of antipsychotic-naive individuals with non-affective psychosis |
title_fullStr | Metabolic profile of antipsychotic-naive individuals with non-affective psychosis |
title_full_unstemmed | Metabolic profile of antipsychotic-naive individuals with non-affective psychosis |
title_short | Metabolic profile of antipsychotic-naive individuals with non-affective psychosis |
title_sort | metabolic profile of antipsychotic-naive individuals with non-affective psychosis |
title_unstemmed | Metabolic profile of antipsychotic-naive individuals with non-affective psychosis |
topic | Psychiatry and Mental health |
url | http://dx.doi.org/10.1192/bjp.bp.108.052605 |